Epidemiology of Acromegaly: Review of population studies

Research output: Contribution to journalArticlepeer-review

Standard

Epidemiology of Acromegaly: Review of population studies. / Lavrentaki, A; Karavitaki, Niki; Paluzzi, A; Wass, John A H.

In: Pituitary, Vol. 20, No. 1, 02.2017, p. 4–9.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Lavrentaki, A ; Karavitaki, Niki ; Paluzzi, A ; Wass, John A H. / Epidemiology of Acromegaly: Review of population studies. In: Pituitary. 2017 ; Vol. 20, No. 1. pp. 4–9.

Bibtex

@article{9adadb0b3f5241f1bf4b3a4c44e38fcf,
title = "Epidemiology of Acromegaly: Review of population studies",
abstract = "Acromegaly is a rare condition necessitating large population studies for the generation of reliable epidemiological data. In this review, we systematically analysed the epidemiological profile of this condition based on recently published population studies from various geographical areas. The total prevalence ranges between 2.8 and 13.7 cases per 100,000 people and the annual incidence rates range between 0.2 and 1.1 cases/100,000 people. The median age at diagnosis is in the fifth decade of life with a median diagnostic delay of 4.5-5 years. Acral enlargement and coarse facial features are the most commonly described clinical manifestations. At the time of detection, most of the tumors are macroadenomas possibly relating to diagnostic delays and posing challenges in the surgical management. Increased awareness of acromegaly amongst the medical community is of major importance aiming to reduce the adverse sequelae of late diagnosis and treatment, improve patient outcomes and, hopefully, reduce the burden on the health care system.",
keywords = "Acromegaly, Incidence, Prevalence, Epidemiology",
author = "A Lavrentaki and Niki Karavitaki and A Paluzzi and Wass, {John A H}",
year = "2017",
month = feb,
doi = "10.1007/s11102-016-0754-x",
language = "English",
volume = "20",
pages = "4–9",
journal = "Pituitary",
issn = "1386-341X",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - Epidemiology of Acromegaly: Review of population studies

AU - Lavrentaki, A

AU - Karavitaki, Niki

AU - Paluzzi, A

AU - Wass, John A H

PY - 2017/2

Y1 - 2017/2

N2 - Acromegaly is a rare condition necessitating large population studies for the generation of reliable epidemiological data. In this review, we systematically analysed the epidemiological profile of this condition based on recently published population studies from various geographical areas. The total prevalence ranges between 2.8 and 13.7 cases per 100,000 people and the annual incidence rates range between 0.2 and 1.1 cases/100,000 people. The median age at diagnosis is in the fifth decade of life with a median diagnostic delay of 4.5-5 years. Acral enlargement and coarse facial features are the most commonly described clinical manifestations. At the time of detection, most of the tumors are macroadenomas possibly relating to diagnostic delays and posing challenges in the surgical management. Increased awareness of acromegaly amongst the medical community is of major importance aiming to reduce the adverse sequelae of late diagnosis and treatment, improve patient outcomes and, hopefully, reduce the burden on the health care system.

AB - Acromegaly is a rare condition necessitating large population studies for the generation of reliable epidemiological data. In this review, we systematically analysed the epidemiological profile of this condition based on recently published population studies from various geographical areas. The total prevalence ranges between 2.8 and 13.7 cases per 100,000 people and the annual incidence rates range between 0.2 and 1.1 cases/100,000 people. The median age at diagnosis is in the fifth decade of life with a median diagnostic delay of 4.5-5 years. Acral enlargement and coarse facial features are the most commonly described clinical manifestations. At the time of detection, most of the tumors are macroadenomas possibly relating to diagnostic delays and posing challenges in the surgical management. Increased awareness of acromegaly amongst the medical community is of major importance aiming to reduce the adverse sequelae of late diagnosis and treatment, improve patient outcomes and, hopefully, reduce the burden on the health care system.

KW - Acromegaly

KW - Incidence

KW - Prevalence

KW - Epidemiology

U2 - 10.1007/s11102-016-0754-x

DO - 10.1007/s11102-016-0754-x

M3 - Article

C2 - 27743174

VL - 20

SP - 4

EP - 9

JO - Pituitary

JF - Pituitary

SN - 1386-341X

IS - 1

ER -